Although the RhoA/ROCK signalling pathway is of increasing importance in cardiovascular disease therapy, ROCK inhibition is not the classic method for diabetic cardiomyopathy therapy compared with glucose control. The gene discussed is RHOA; the disease is cardiovascular disorder.